XORTX Therapeutics Inc. Common Stock
Symbol: XRTX (NASDAQ)
0.80
▼ (-5.05%) -0.042
Company Description:
XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.
Key Stats
- Today's Open: $0.812
- Today's High: $0.812
- Today's Low: $0.771
- Today's Volume: 309
- Yesterday Close: $0.8404
- Yesterday High: $0.859
- Yesterday Low: $0.8133
- Yesterday Volume: 43.73K
- Last Min Volume: 50
- Last Min High: $0.798
- Last Min Low: $0.775
- Last Min VWAP: $0.775
Company Profile
- Name: XORTX Therapeutics Inc. Common Stock
- Website: https://www.xortx.com
- Listed Date: 2018-05-04
- Location: ,
- Market Status: Active
- CIK Number: 0001729214
- SIC Code:
- SIC description:
- Market Cap: $4.38M
- Round Lot: 100
- Outstanding Shares: 5.21M
- Asset Type: CS
RECENT FILINGS FOR XRTX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-04 | 6-K | View |
| 2025-09-03 | 6-K | View |
| 2025-08-15 | 6-K | View |
| 2025-08-07 | 6-K | View |
| 2025-06-26 | 6-K | View |
| 2025-05-19 | 6-K | View |
| 2025-05-16 | 6-K | View |
| 2025-05-15 | SCHEDULE 13G/A | View |
| 2025-05-12 | 20-F | View |
| 2025-05-01 | NT 20-F | View |
| 2025-04-30 | 6-K | View |
| 2025-04-28 | 6-K | View |
| 2025-04-18 | 6-K | View |
| 2025-04-01 | 6-K | View |
| 2025-03-26 | 6-K | View |
| 2025-03-19 | 6-K | View |
| 2025-02-24 | 6-K | View |
| 2025-02-14 | SCHEDULE 13G | View |
| 2025-01-29 | 6-K | View |
| 2025-01-22 | 6-K | View |